0G8X.L
IMMUNOVIA AB (PUBL) IMMUNOVIA O
£0.22
+1.59%
2026-05-28
About IMMUNOVIA AB (PUBL) IMMUNOVIA O
Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Key Fundamentals
EPS (TTM)
£-7.80
ROE
-281.3%
Revenue Growth (YoY)
205.0%
Profit Margin
0.0%
Debt/Equity
1.32
Price/Book
3.23
Beta
2.66
Market Cap
£3.9M
Avg Volume (10D)
19K
Recent Breakout Signals
No recent breakout signals detected for 0G8X.L.
Recent Price Range (60 Days)
60D High
£0.29
60D Low
£0.15
Avg Volume
71K
Latest Close
£0.22
Get breakout alerts for 0G8X.L
Sign up for Breakout Scanner to receive daily notifications when 0G8X.L triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
IMMUNOVIA AB (PUBL) IMMUNOVIA O (0G8X.L) is listed on the London Stock Exchange (LSE). Breakout Scanner monitors 0G8X.L daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups.. Data is provided for informational purposes only and does not constitute financial advice.